{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:50:48Z","timestamp":1787637048138,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12192-0","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:06:51Z","timestamp":1782562011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurotherapeutic roles of the protective arm of the renin\u2013angiotensin system: from inflammation to cognitive rescue"],"prefix":"10.1007","volume":"53","author":[{"given":"Amirali","family":"Ebrahimbabaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava Soltani","family":"Hekmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Javanmardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"4","key":"12192_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD et al (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(4):344\u2013381","journal-title":"Lancet Neurol"},{"issue":"4","key":"12192_CR2","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1007\/s00415-021-10774-5","volume":"269","author":"A Raggi","year":"2022","unstructured":"Raggi A, Monasta L, Beghi E, Caso V, Castelpietra G, Mondello S, Giussani G, Logroscino G, Magnani FG, Piccininni M, Pupillo E, Ricci S, Ronfani L, Santalucia P, Sattin D, Schiavolin S, Toppo C, Traini E, Steinmetz J, Nichols E, Ma R, Vos T, Feigin V, Leonardi M (2022) Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019. J Neurol 269(4):2080\u20132098","journal-title":"J Neurol"},{"key":"12192_CR3","doi-asserted-by":"publisher","first-page":"101675","DOI":"10.1016\/j.eclinm.2022.101675","volume":"54","author":"D Arias","year":"2022","unstructured":"Arias D, Saxena S, Verguet S (2022) Quantifying the global burden of mental disorders and their economic value. EClinicalMedicine 54:101675","journal-title":"EClinicalMedicine"},{"issue":"8","key":"12192_CR4","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/life15081333","volume":"15","author":"C Cueto-Ure\u00f1a","year":"2025","unstructured":"Cueto-Ure\u00f1a C et al (2025) Physiopathology of the Brain Renin-Angiotensin System. Life 15(8):1333","journal-title":"Life"},{"key":"12192_CR5","doi-asserted-by":"publisher","first-page":"149739","DOI":"10.1016\/j.brainres.2025.149739","volume":"1863","author":"MJ Campagnole-Santos","year":"2025","unstructured":"Campagnole-Santos MJ et al (2025) ACE2\/Angiotensin-(1\u20137)\/Mas and the brain. Brain Res 1863:149739","journal-title":"Brain Res"},{"key":"12192_CR6","doi-asserted-by":"publisher","first-page":"1565270","DOI":"10.3389\/fphys.2025.1565270","volume":"16","author":"LC Lucas","year":"2025","unstructured":"Lucas LC et al (2025) Angiotensin-(1\u20137) protective effects in neurocognitive disorders: molecular mechanisms to therapeutic implications. Front Physiol 16:1565270","journal-title":"Front Physiol"},{"issue":"1","key":"12192_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1124\/jpet.120.000397","volume":"377","author":"S Khajehpour","year":"2021","unstructured":"Khajehpour S, Aghazadeh-Habashi A (2021) Targeting the protective arm of the renin-angiotensin system: Focused on angiotensin-(1\u20137). J Pharmacol Exp Ther 377(1):64\u201374","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"12192_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.amjmed.2003.09.034","volume":"116","author":"UC Brewster","year":"2004","unstructured":"Brewster UC, Perazella MA (2004) The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 116(4):263\u2013272","journal-title":"Am J Med"},{"key":"12192_CR9","doi-asserted-by":"publisher","first-page":"977039","DOI":"10.3389\/fncel.2022.977039","volume":"16","author":"LA M\u00e9ndez-Garc\u00eda","year":"2022","unstructured":"M\u00e9ndez-Garc\u00eda LA et al (2022) Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations. Front Cell Neurosci 16:977039","journal-title":"Front Cell Neurosci"},{"key":"12192_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fendo.2014.00113","volume":"5","author":"DJ Campbell","year":"2014","unstructured":"Campbell DJ (2014) Clinical relevance of local renin angiotensin systems. Front Endocrinol 5:113","journal-title":"Front Endocrinol"},{"key":"12192_CR11","doi-asserted-by":"publisher","first-page":"105796","DOI":"10.1016\/j.intimp.2019.105796","volume":"75","author":"Y Wu","year":"2019","unstructured":"Wu Y et al (2019) Renin-angiotensin system in osteoarthritis: a new potential therapy. Int Immunopharmacol 75:105796","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"12192_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1042\/CS20171550","volume":"133","author":"AM South","year":"2019","unstructured":"South AM et al (2019) Fetal programming and the angiotensin-(1\u20137) axis: a review of the experimental and clinical data. Clin Sci 133(1):55\u201374","journal-title":"Clin Sci"},{"issue":"5","key":"12192_CR13","doi-asserted-by":"publisher","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","volume":"316","author":"RAS Santos","year":"2019","unstructured":"Santos RAS et al (2019) The renin-angiotensin system: going beyond the classical paradigms. Am J Physiol Heart Circ Physiol 316(5):H958\u2013H970","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"12192_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1089\/ars.2013.5302","volume":"20","author":"AC Montezano","year":"2014","unstructured":"Montezano AC, Touyz RM (2014) Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research. Antioxid Redox Signal 20(1):164\u2013182","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"12192_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/1440-1681.12137","volume":"40","author":"C Sumners","year":"2013","unstructured":"Sumners C et al (2013) Protective arms of the renin\u2013angiotensin-system in neurological disease. Clin Exp Pharmacol Physiol 40(8):580\u2013588","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"12192_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","volume":"98","author":"RAS Santos","year":"2018","unstructured":"Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ (2018) The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiol Rev 98(1):505\u2013553","journal-title":"Physiol Rev"},{"issue":"1","key":"12192_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BJ20040634","volume":"383","author":"GI Rice","year":"2004","unstructured":"Rice GI et al (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383(1):45\u201351","journal-title":"Biochem J"},{"issue":"22","key":"12192_CR18","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1042\/CS20200922","volume":"134","author":"UM Steckelings","year":"2020","unstructured":"Steckelings UM, Sumners C (2020) Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Clin Sci 134(22):2987\u20133006","journal-title":"Clin Sci"},{"issue":"14","key":"12192_CR19","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"RA de Santos","year":"2003","unstructured":"Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100(14):8258\u20138263","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"12192_CR20","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1161\/HYPERTENSIONAHA.116.08118","volume":"68","author":"S Galandrin","year":"2016","unstructured":"Galandrin S et al (2016) Cardioprotective angiotensin-(1\u20137) peptide acts as a natural-biased ligand at the angiotensin II type 1 receptor. Hypertension 68(6):1365\u20131374","journal-title":"Hypertension"},{"issue":"3","key":"12192_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1042\/CS20130396","volume":"127","author":"J Gao","year":"2014","unstructured":"Gao J et al (2014) A new strategy for treating hypertension by blocking the activity of the brain renin\u2013angiotensin system with aminopeptidase A inhibitors. Clin Sci 127(3):135\u2013148","journal-title":"Clin Sci"},{"issue":"5","key":"12192_CR22","doi-asserted-by":"publisher","first-page":"C1318","DOI":"10.1152\/ajpcell.00036.2009","volume":"297","author":"M Iwata","year":"2009","unstructured":"Iwata M, Silva Enciso JE, Greenberg BH (2009) Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor \u03b1-converting enzyme. Am J Physiology-Cell Physiol 297(5):C1318\u2013C1329","journal-title":"Am J Physiology-Cell Physiol"},{"key":"12192_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","volume":"66","author":"VB Patel","year":"2014","unstructured":"Patel VB et al (2014) Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol 66:167\u2013176","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"12192_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M et al (2000) A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circul Res 87(5):e1\u2013e9","journal-title":"Circul Res"},{"issue":"5","key":"12192_CR25","first-page":"446","volume":"2","author":"Z Kassiri","year":"2009","unstructured":"Kassiri Z et al (2009) Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circulation: Heart Fail 2(5):446\u2013455","journal-title":"Circulation: Heart Fail"},{"issue":"6","key":"12192_CR26","doi-asserted-by":"publisher","first-page":"F1523","DOI":"10.1152\/ajprenal.00426.2009","volume":"298","author":"M Dilauro","year":"2010","unstructured":"Dilauro M et al (2010) Effect of ACE2 and angiotensin-(1\u20137) in a mouse model of early chronic kidney disease. Am J Physiology-Renal Physiol 298(6):F1523\u2013F1532","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"8","key":"12192_CR27","doi-asserted-by":"publisher","first-page":"F812","DOI":"10.1152\/ajprenal.00655.2013","volume":"306","author":"J Mori","year":"2014","unstructured":"Mori J et al (2014) Angiotensin 1\u20137 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity. Am J Physiology-Renal Physiol 306(8):F812\u2013F821","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"8","key":"12192_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1042\/CS20100280","volume":"120","author":"E Velkoska","year":"2011","unstructured":"Velkoska E et al (2011) Angiotensin-(1\u20137) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. Clin Sci 120(8):335\u2013345","journal-title":"Clin Sci"},{"issue":"3","key":"12192_CR29","doi-asserted-by":"publisher","first-page":"H1416","DOI":"10.1152\/ajpheart.00141.2007","volume":"293","author":"LK Becker","year":"2007","unstructured":"Becker LK et al (2007) Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol 293(3):H1416\u2013H1424","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"12192_CR30","doi-asserted-by":"crossref","unstructured":"Rukavina Mikusic NL, Pineda AM, Gironacci MM (2021) Angiotensin-(1\u20137) and Mas receptor in the brain.","DOI":"10.37349\/emed.2021.00046"},{"issue":"10","key":"12192_CR31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","volume":"96","author":"AP Mecca","year":"2011","unstructured":"Mecca AP et al (2011) Cerebroprotection by angiotensin-(1\u20137) in endothelin\u20101\u2010induced ischaemic stroke. Exp Physiol 96(10):1084\u20131096","journal-title":"Exp Physiol"},{"issue":"1","key":"12192_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-023-01266-0","volume":"26","author":"Z Zhou","year":"2024","unstructured":"Zhou Z et al (2024) Angiotensin receptor blockers and cognition: a scoping review. Curr Hypertens Rep 26(1):1\u201319","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"12192_CR33","doi-asserted-by":"publisher","first-page":"e18495","DOI":"10.1111\/jcmm.18495","volume":"28","author":"Z Al-Qahtani","year":"2024","unstructured":"Al-Qahtani Z et al (2024) The potential role of brain renin\u2010angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat? J Cell Mol Med 28(12):e18495","journal-title":"J Cell Mol Med"},{"issue":"7","key":"12192_CR34","first-page":"e87557","volume":"17","author":"MK Subhani","year":"2025","unstructured":"Subhani MK, Sabani A, Omer O, Kheirelsid F, Srour AK (2025) Impact of Renin-Angiotensin-Aldosterone System Modulation on Cognitive and Neuropsychiatric Outcomes: A Systematic Review of Clinical and Mechanistic Evidence. Cureus 17(7):e87557","journal-title":"Cureus"},{"key":"12192_CR35","doi-asserted-by":"publisher","first-page":"149400","DOI":"10.1016\/j.brainres.2024.149400","volume":"1850","author":"S Yasmin","year":"2025","unstructured":"Yasmin S et al (2025) The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update. Brain Res 1850:149400","journal-title":"Brain Res"},{"issue":"8","key":"12192_CR36","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","volume":"112","author":"RQ Lautner","year":"2013","unstructured":"Lautner RQ et al (2013) Discovery and characterization of alamandine: a novel component of the renin\u2013angiotensin system. Circul Res 112(8):1104\u20131111","journal-title":"Circul Res"},{"issue":"6","key":"12192_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11906-014-0433-0","volume":"16","author":"GM Etelvino","year":"2014","unstructured":"Etelvino GM, Peluso AAB, Santos RAS (2014) New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D. Curr Hypertens Rep 16(6):433","journal-title":"Curr Hypertens Rep"},{"key":"12192_CR38","doi-asserted-by":"publisher","first-page":"170101","DOI":"10.1016\/j.peptides.2019.170101","volume":"118","author":"J Gong","year":"2019","unstructured":"Gong J et al (2019) Superoxide anions mediate the effects of angiotensin (1\u20137) analog, alamandine, on blood pressure and sympathetic activity in the paraventricular nucleus. Peptides 118:170101","journal-title":"Peptides"},{"key":"12192_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fmed.2019.00107","volume":"6","author":"J Schleifenbaum","year":"2019","unstructured":"Schleifenbaum J (2019) Alamandine and its receptor MrgD pair up to join the protective arm of the renin-angiotensin system. Front Med 6:107","journal-title":"Front Med"},{"issue":"1\u20133","key":"12192_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0014-5793(02)02775-8","volume":"520","author":"S Takeda","year":"2002","unstructured":"Takeda S et al (2002) Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 520(1\u20133):97\u2013101","journal-title":"FEBS Lett"},{"issue":"17","key":"12192_CR41","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1073\/pnas.1732949100","volume":"100","author":"MJ Zylka","year":"2003","unstructured":"Zylka MJ, Dong X, Southwell AL, Anderson DJ (2003) Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc Natl Acad Sci U S A 100(17):10043\u201310048","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"12192_CR42","doi-asserted-by":"publisher","first-page":"14532","DOI":"10.1523\/JNEUROSCI.3509-12.2012","volume":"32","author":"Q Liu","year":"2012","unstructured":"Liu Q et al (2012) Mechanisms of itch evoked by \u03b2-alanine. J Neurosci 32(42):14532\u201314537","journal-title":"J Neurosci"},{"issue":"26","key":"12192_CR43","doi-asserted-by":"publisher","first-page":"8612","DOI":"10.1523\/JNEUROSCI.1057-09.2009","volume":"29","author":"KK Rau","year":"2009","unstructured":"Rau KK et al (2009) Mrgprd enhances excitability in specific populations of cutaneous murine polymodal nociceptors. J Neurosci 29(26):8612\u20138619","journal-title":"J Neurosci"},{"key":"12192_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gene.2005.03.001","volume":"352","author":"S Yang","year":"2005","unstructured":"Yang S et al (2005) Adaptive evolution of MRGX2, a human sensory neuron specific gene involved in nociception. Gene 352:30\u201335","journal-title":"Gene"},{"issue":"9","key":"12192_CR45","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2174\/0929866524666170822120258","volume":"24","author":"AF Almeida-Santos","year":"2017","unstructured":"Almeida-Santos AF, Kangussu LM, Campagnole-Santos MJ (2017) The renin-angiotensin system and the neurodegenerative diseases: a brief review. Protein Pept Lett 24(9):841\u2013853","journal-title":"Protein Pept Lett"},{"issue":"7","key":"12192_CR46","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","volume":"127","author":"T Shabab","year":"2017","unstructured":"Shabab T et al (2017) Neuroinflammation pathways: a general review. Int J Neurosci 127(7):624\u2013633","journal-title":"Int J Neurosci"},{"key":"12192_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0486-x","volume":"13","author":"S Swaroop","year":"2016","unstructured":"Swaroop S et al (2016) HSP60 plays a regulatory role in IL-1\u03b2-induced microglial inflammation via TLR4-p38 MAPK axis. J Neuroinflamm 13:1\u201319","journal-title":"J Neuroinflamm"},{"key":"12192_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbi.2015.10.010","volume":"52","author":"F Su","year":"2016","unstructured":"Su F, Bai F, Zhou H, Zhang Z (2016) Microglial toll-like receptors and Alzheimer's disease. Brain Behav Immun 52:187\u2013198","journal-title":"Brain Behav Immun"},{"issue":"1\u20132","key":"12192_CR49","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0891-5849(96)00269-9","volume":"22","author":"L Packer","year":"1997","unstructured":"Packer L, Tritschler HJ, Wessel K (1997) Neuroprotection by the metabolic antioxidant \u03b1-lipoic acid. Free Radic Biol Med 22(1\u20132):359\u2013378","journal-title":"Free Radic Biol Med"},{"key":"12192_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","volume":"79","author":"M Lyman","year":"2014","unstructured":"Lyman M et al (2014) Neuroinflammation: the role and consequences. Neurosci Res 79:1\u201312","journal-title":"Neurosci Res"},{"key":"12192_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-4-47","volume":"4","author":"TC Frank-Cannon","year":"2009","unstructured":"Frank-Cannon TC et al (2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol neurodegeneration 4:1\u201313","journal-title":"Mol neurodegeneration"},{"issue":"16","key":"12192_CR52","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2174\/138161212800165997","volume":"18","author":"N Sismanopoulos","year":"2012","unstructured":"Sismanopoulos N et al (2012) Mast cells in allergic and inflammatory diseases. Curr Pharm Design 18(16):2261\u20132277","journal-title":"Curr Pharm Design"},{"issue":"9","key":"12192_CR53","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.4049\/jimmunol.171.9.4830","volume":"171","author":"K Kandere-Grzybowska","year":"2003","unstructured":"Kandere-Grzybowska K et al (2003) IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 171(9):4830\u20134836","journal-title":"J Immunol"},{"key":"12192_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-8-25","volume":"8","author":"DY Kim","year":"2011","unstructured":"Kim DY, Hong GU, Ro JY (2011) Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflamm 8:1\u201316","journal-title":"J Neuroinflamm"},{"issue":"22","key":"12192_CR55","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1089\/neu.2019.6376","volume":"36","author":"ZC Janatpour","year":"2019","unstructured":"Janatpour ZC et al (2019) Subcutaneous administration of angiotensin-(1\u20137) improves recovery after traumatic brain injury in mice. J Neurotrauma 36(22):3115\u20133131","journal-title":"J Neurotrauma"},{"issue":"1","key":"12192_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/jnc.13386","volume":"136","author":"M Liu","year":"2016","unstructured":"Liu M, Shi P, Sumners C (2016) Direct anti-inflammatory effects of angiotensin\u2010(1\u20137) on microglia. J Neurochem 136(1):163\u2013171","journal-title":"J Neurochem"},{"key":"12192_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuroscience.2014.04.060","volume":"273","author":"J Zheng","year":"2014","unstructured":"Zheng J et al (2014) Activation of the ACE2\/Ang-(1\u20137)\/Mas pathway reduces oxygen\u2013glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction. Neuroscience 273:39\u201351","journal-title":"Neuroscience"},{"key":"12192_CR58","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuropharm.2014.01.044","volume":"81","author":"JP Joseph","year":"2014","unstructured":"Joseph JP et al (2014) The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke. Neuropharmacology 81:134\u2013141","journal-title":"Neuropharmacology"},{"issue":"1","key":"12192_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12868-024-00876-x","volume":"25","author":"DN Olschewski","year":"2024","unstructured":"Olschewski DN et al (2024) The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke. BMC Neurosci 25(1):29","journal-title":"BMC Neurosci"},{"key":"12192_CR60","doi-asserted-by":"publisher","first-page":"173035","DOI":"10.1016\/j.ejphar.2020.173035","volume":"875","author":"P Conti","year":"2020","unstructured":"Conti P et al (2020) Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37. Eur J Pharmacol 875:173035","journal-title":"Eur J Pharmacol"},{"issue":"35","key":"12192_CR61","doi-asserted-by":"publisher","first-page":"14942","DOI":"10.1073\/pnas.0903602106","volume":"106","author":"J Stegbauer","year":"2009","unstructured":"Stegbauer J et al (2009) Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci 106(35):14942\u201314947","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"12192_CR62","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/1352458508097923","volume":"15","author":"M Kawajiri","year":"2009","unstructured":"Kawajiri M et al (2009) Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis. Multiple Scler J 15(2):262\u2013265","journal-title":"Multiple Scler J"},{"issue":"14","key":"12192_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.02-1193fje","volume":"17","author":"K Reinecke","year":"2003","unstructured":"Reinecke K et al (2003) Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-\u03baB. FASEB J 17(14):1\u201321","journal-title":"FASEB J"},{"issue":"7","key":"12192_CR64","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/j.1532-2149.2012.00269.x","volume":"17","author":"U Anand","year":"2013","unstructured":"Anand U et al (2013) Angiotensin II type 2 receptor (AT2R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons. Eur J Pain 17(7):1012\u20131026","journal-title":"Eur J Pain"},{"issue":"9","key":"12192_CR65","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/sj.jcbfm.9600273","volume":"26","author":"M-Z Zhao","year":"2006","unstructured":"Zhao M-Z et al (2006) Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J Cereb Blood Flow Metabolism 26(9):1176\u20131188","journal-title":"J Cereb Blood Flow Metabolism"},{"issue":"1","key":"12192_CR66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.jcbfm.9600311","volume":"27","author":"LH Shen","year":"2007","unstructured":"Shen LH et al (2007) Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metabolism 27(1):6\u201313","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"12192_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2012.04.070","volume":"216","author":"F Lopez-Aguilera","year":"2012","unstructured":"Lopez-Aguilera F et al (2012) Hypoxic preconditioning induces an AT2-R\/VEGFR-2 (Flk-1) interaction in the neonatal brain microvasculature for neuroprotection. Neuroscience 216:1\u20139","journal-title":"Neuroscience"},{"issue":"7","key":"12192_CR68","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","volume":"167","author":"T Jiang","year":"2012","unstructured":"Jiang T et al (2012) Suppressing inflammation by inhibiting the NF-\u03baB pathway contributes to the neuroprotective effect of angiotensin\u2010(1\u20107) in rats with permanent cerebral ischaemia. Br J Pharmacol 167(7):1520\u20131532","journal-title":"Br J Pharmacol"},{"issue":"2","key":"12192_CR69","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/jcbfm.2011.133","volume":"32","author":"F Jing","year":"2012","unstructured":"Jing F et al (2012) Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metabolism 32(2):248\u2013255","journal-title":"J Cereb Blood Flow Metabolism"},{"issue":"11","key":"12192_CR70","doi-asserted-by":"publisher","first-page":"e48387","DOI":"10.1371\/journal.pone.0048387","volume":"7","author":"K Ohshima","year":"2012","unstructured":"Ohshima K et al (2012) Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPAR\u03b3 activation. PLoS ONE 7(11):e48387","journal-title":"PLoS ONE"},{"issue":"3","key":"12192_CR71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mcn.2005.03.012","volume":"29","author":"K Hellner","year":"2005","unstructured":"Hellner K et al (2005) Angiotensin-(1\u20137) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci 29(3):427\u2013435","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"12192_CR72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nlm.2011.10.003","volume":"97","author":"TL Lazaroni","year":"2012","unstructured":"Lazaroni TL et al (2012) Angiotensin-(1\u20137)\/Mas axis integrity is required for the expression of object recognition memory. Neurobiol Learn Mem 97(1):113\u2013123","journal-title":"Neurobiol Learn Mem"},{"issue":"4","key":"12192_CR73","doi-asserted-by":"publisher","first-page":"R804","DOI":"10.1152\/ajpregu.00222.2010","volume":"300","author":"P Xu","year":"2011","unstructured":"Xu P, Sriramula S, Lazartigues E (2011) ACE2\/ANG-(1\u20137)\/Mas pathway in the brain: the axis of good. Am J Physiology-Regulatory Integr Comp Physiol 300(4):R804\u2013R817","journal-title":"Am J Physiology-Regulatory Integr Comp Physiol"},{"issue":"4","key":"12192_CR74","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1161\/STROKEAHA.108.531509","volume":"40","author":"CA McCarthy","year":"2009","unstructured":"McCarthy CA et al (2009) Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 40(4):1482\u20131489","journal-title":"Stroke"},{"issue":"28","key":"12192_CR75","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2174\/0929867325666180226102358","volume":"25","author":"NP Rocha","year":"2018","unstructured":"Rocha NP et al (2018) RAS in the central nervous system: potential role in neuropsychiatric disorders. Curr Med Chem 25(28):3333\u20133352","journal-title":"Curr Med Chem"},{"issue":"8","key":"12192_CR76","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP-Y (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19(8):477\u2013489","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"12192_CR77","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N et al (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20(13):3328","journal-title":"Int J Mol Sci"},{"issue":"7784","key":"12192_CR78","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669\u2013673","journal-title":"Nature"},{"issue":"2","key":"12192_CR79","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/antiox11020329","volume":"11","author":"A Quijano","year":"2022","unstructured":"Quijano A et al (2022) Angiotensin type-1 receptor inhibition reduces NLRP3 inflammasome upregulation induced by aging and neurodegeneration in the substantia nigra of male rodents and primary mesencephalic cultures. Antioxidants 11(2):329","journal-title":"Antioxidants"},{"issue":"10","key":"12192_CR80","doi-asserted-by":"publisher","first-page":"e13480","DOI":"10.1111\/acel.13480","volume":"20","author":"R Dang","year":"2021","unstructured":"Dang R et al (2021) Activation of angiotensin-converting enzyme 2\/angiotensin (1\u20137)\/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling. Aging Cell 20(10):e13480","journal-title":"Aging Cell"},{"key":"12192_CR81","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.2147\/JIR.S343575","volume":"14","author":"R Duan","year":"2021","unstructured":"Duan R, Wang SY, Wei B, Deng Y, Fu XX, Gong PY, E Y, Sun XJ, Cao HM, Shi JQ, Jiang T, Zhang YD (2021) Angiotensin-(1-7) Analogue AVE0991 Modulates Astrocyte-Mediated Neuroinflammation via lncRNA SNHG14\/miR-223-3p\/NLRP3 Pathway and Offers Neuroprotection in a Transgenic Mouse Model of Alzheimer's Disease. J Inflamm Res 14:7007\u20137019","journal-title":"J Inflamm Res"},{"issue":"43","key":"12192_CR82","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1073\/pnas.1606171113","volume":"113","author":"L Katsouri","year":"2016","unstructured":"Katsouri L et al (2016) PPAR\u03b3-coactivator-1\u03b1 gene transfer reduces neuronal loss and amyloid-\u03b2 generation by reducing \u03b2-secretase in an Alzheimer\u2019s disease model. Proc Natl Acad Sci 113(43):12292\u201312297","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"12192_CR83","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.20160534","volume":"214","author":"M-A-M Ismail","year":"2017","unstructured":"Ismail M-A-M et al (2017) 27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP\/GLUT4 system dysregulation. J Exp Med 214(3):699\u2013717","journal-title":"J Exp Med"},{"issue":"563","key":"12192_CR84","doi-asserted-by":"publisher","first-page":"eaaz2541","DOI":"10.1126\/scitranslmed.aaz2541","volume":"12","author":"LK Cuddy","year":"2020","unstructured":"Cuddy LK et al (2020) A\u03b2-accelerated neurodegeneration caused by Alzheimer\u2019s-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice. Sci Transl Med 12(563):eaaz2541","journal-title":"Sci Transl Med"},{"issue":"1","key":"12192_CR85","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11011-025-01780-x","volume":"41","author":"G Singh","year":"2026","unstructured":"Singh G, Maparu K, Aran KR (2026) Neuro-renin\u2013angiotensin\u2013aldosterone system axis in alzheimer\u2019s disease: from molecular dysregulation to therapeutic redirection. Metab Brain Dis 41(1):36","journal-title":"Metab Brain Dis"},{"issue":"2","key":"12192_CR86","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuroscience.2003.12.006","volume":"124","author":"J Lee","year":"2004","unstructured":"Lee J et al (2004) Effect of ICV injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats. Neuroscience 124(2):341\u2013349","journal-title":"Neuroscience"},{"issue":"3","key":"12192_CR87","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/ana.410320306","volume":"32","author":"AM Allen","year":"1992","unstructured":"Allen AM et al (1992) Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Annals Neurology: Official J Am Neurol Association Child Neurol Soc 32(3):339\u2013344","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"issue":"2","key":"12192_CR88","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/cne.902910203","volume":"291","author":"SY Chai","year":"1990","unstructured":"Chai SY et al (1990) Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography. J Comp Neurol 291(2):179\u2013194","journal-title":"J Comp Neurol"},{"issue":"1","key":"12192_CR89","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-024-00410-3","volume":"13","author":"JL Labandeira-Garcia","year":"2024","unstructured":"Labandeira-Garcia JL et al (2024) The role of the brain renin-angiotensin system in Parkinson s disease. Translational neurodegeneration 13(1):22","journal-title":"Translational neurodegeneration"},{"issue":"1","key":"12192_CR90","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1445-5994.2000.tb01054.x","volume":"30","author":"K Reardon","year":"2000","unstructured":"Reardon K et al (2000) The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson\u2019s disease. Aust N Z J Med 30(1):48\u201353","journal-title":"Aust N Z J Med"},{"issue":"3","key":"12192_CR91","first-page":"329","volume":"57","author":"S Faure","year":"2006","unstructured":"Faure S, Chapot R, Tallet D, Javellaud J, Achard JM, Oudart N (2006) Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors. J Physiol Pharmacol 57(3):329\u2013342","journal-title":"J Physiol Pharmacol"},{"issue":"1","key":"12192_CR92","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/jpet.118.254854","volume":"369","author":"M Hay","year":"2019","unstructured":"Hay M et al (2019) A novel angiotensin-(1\u20137) glycosylated mas receptor agonist for treating vascular cognitive impairment and inflammation-related memory dysfunction. J Pharmacol Exp Ther 369(1):9\u201325","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"12192_CR93","first-page":"1927","volume":"15","author":"C Hoyer-Kimura","year":"2024","unstructured":"Hoyer-Kimura C, Hay M, Konhilas JP, Morrison HW, Methajit M, Strom J, Polt R, Salcedo V, Fricks JP, Kalya A, Pires PW (2024) PNA5, A Novel Mas Receptor Agonist, Improves Neurovascular and Blood-Brain-Barrier Function in a Mouse Model of Vascular Cognitive Impairment and Dementia. Aging Dis 15(4):1927\u20131951","journal-title":"Aging Dis"},{"key":"12192_CR94","doi-asserted-by":"publisher","first-page":"114926","DOI":"10.1016\/j.expneurol.2024.114926","volume":"381","author":"K Bernard","year":"2024","unstructured":"Bernard K et al (2024) The angiotensin (1\u20137) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson\u2019s disease through modulation of neuroinflammation. Exp Neurol 381:114926","journal-title":"Exp Neurol"},{"issue":"3","key":"12192_CR95","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/pharmaceutics14030587","volume":"14","author":"D Encinas-Basurto","year":"2022","unstructured":"Encinas-Basurto D et al (2022) Glycosylated Ang-(1\u20137) MasR agonist peptide poly lactic-co-glycolic acid (PLGA) nanoparticles and microparticles in cognitive impairment: design, particle preparation, physicochemical characterization, and in vitro release. Pharmaceutics 14(3):587","journal-title":"Pharmaceutics"},{"key":"12192_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","volume":"165","author":"R Pandit","year":"2020","unstructured":"Pandit R, Chen L, G\u00f6tz J (2020) The blood-brain barrier: Physiology and strategies for drug delivery. Adv Drug Deliv Rev 165:1\u201314","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"12192_CR97","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.4103\/1673-5374.270304","volume":"15","author":"ZC Janatpour","year":"2020","unstructured":"Janatpour ZC, Symes AJ (2020) The extended renin-angiotensin system: a promising target for traumatic brain injury therapeutics. Neural Regeneration Res 15(6):1025\u20131026","journal-title":"Neural Regeneration Res"},{"key":"12192_CR98","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12325-010-0028-3","volume":"27","author":"HM Siragy","year":"2010","unstructured":"Siragy HM (2010) Comparing angiotensin II receptor blockers on benefits beyond blood pressure. Adv therapy 27:257\u2013284","journal-title":"Adv therapy"},{"key":"12192_CR99","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fendo.2013.00158","volume":"4","author":"JW Wright","year":"2013","unstructured":"Wright JW, Kawas LH, Harding JW (2013) A role for the brain RAS in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Endocrinol 4:158","journal-title":"Front Endocrinol"},{"issue":"18","key":"12192_CR100","doi-asserted-by":"publisher","first-page":"10139","DOI":"10.3390\/ijms221810139","volume":"22","author":"R Loera-Valencia","year":"2021","unstructured":"Loera-Valencia R et al (2021) Brain renin\u2013angiotensin system as novel and potential therapeutic target for Alzheimer\u2019s disease. Int J Mol Sci 22(18):10139","journal-title":"Int J Mol Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12192-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:03:23Z","timestamp":1782565403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12192-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12192"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12192-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval<!--Emphasis Type='Bold' removed-->and informed consent"}}],"article-number":"1012"}}